Immunoproteasomes at the interface of innate and adaptive immune responses: Two faces of one enzyme

Current Opinion in Immunology

Volumn 24, Issue 1, 2012, Pages 77-83

  Krüger, Elke ^a   Kloetzel, Peter M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

I PROTEASOME; IMMUNOPROTEASOME; INTERFERON; ISOENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CELL PROTECTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INDUCTION; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; HUMANS; IMMUNITY, INNATE; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES;

EID: 84857056178     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.01.005     Document Type: Review

References (53)

1. Rock K.L., Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999, 17:739-779.
2. Liu Y.C., Penninger J., Karin M. Immunity by ubiquitylation: a reversible process of modification. Nat Rev Immunol 2005, 5:941-952.
3. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 2005, 6:79-87.
4. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 1997, 386:463-471.
5. Kloetzel P.M. Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2001, 2:179-187.
6. Strehl B., Seifert U., Krüger E., Heink S., Kuckelkorn U., Kloetzel P.M. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev 2005, 207:19-30.
7. Guillaume B., Chapiro J., Stroobant V., Colau D., Van Holle B., Parvizi G., Bousquet-Dubouch M.P., Theate I., Parmentier N., Van den Eynde B.J. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc Natl Acad Sci USA 2010, 107:18599-18604.
8. Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamura T., Tanahashi N., Yoshimura T., Tanaka K., Ichihara A. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem (Tokyo) 1994, 115:257-269.
9. Seifert U., Bialy L.P., Ebstein F., Bech-Otschir D., Voigt A., Schroter F., Prozorovski T., Lange N., Steffen J., Rieger M., et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010, 142:613-624.
10. Sijts E.J., Kloetzel P.M. The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci 2011, 68:1491-1502.
11. Yewdell J.W. The seven dirty little secrets of major histocompatibility complex calls I antigen processing. Immunol Rev 2005, 207:8-18.
12. Nussbaum A.K., Rodriguez-Carreno M.P., Benning N., Botten J., Whitton J.L. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J Immunol 2005, 175:1153-1160.
13. Groettrup M., Kirk C.J., Basler M. Proteasomes in immune cells: more than peptide producers?. Nat Rev Immunol 2010, 10:73-78.
14. Heink S., Ludwig D., Kloetzel P.M., Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci USA 2005, 102:9241-9246.
15. Ebstein F., Lange N., Urban S., Seifert U., Kruger E., Kloetzel P.M. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol 2009, 41:1205-1215.
16. Macagno A., Gilliet M., Sallusto F., Lanzavecchia A., Nestle F.O., Groettrup M. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur J Immunol 1999, 29:4037-4042.
17. Shin E.C., Seifert U., Kato T., Rice C., Feinstone S.M., Kloetzel P.M., Rehermann B. Virus-induced type I interferon stimulates generation of immunoproteasomes at the site of function. J Clin Invest 2006, 116:3006-3014.
18. Barton L.F., Cruz M., Rangwala R., Deepe G.S., Monaco J.J. Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J Immunol 2002, 169:3046-3052.
19. Rada B., Leto T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 2008, 15:164-187.
20. Orient A., Donko A., Szabo A., Leto T.L., Geiszt M. Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant 2007, 22:1281-1288.
21. Manea A., Tanase L.I., Raicu M., Simionescu M. Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2010, 30:105-112.
22. Pearl-Yafe M., Halperin D., Halevy A., Kalir H., Bielora B., Fabian I. An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cells. Biochem Pharmacol 2003, 65:833-842.
23. Sasaki M., Ikeda H., Sato Y., Nakanuma Y. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic Res 2008, 1-8.
24. Osburn W.O., Kensler T.W. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res 2008, 659:31-39.
25. Szeto J., Kaniuk N., Canadien V., Nisman R., Mizushima N., Yoshimori T., Bazett-Jones D., Brumell J. ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2006, 2:189-199.
26. Fujita K., Maeda D., Xiao Q., Srinivasula S.M. Nrf2-mediated induction of p62 controls Toll-like receptor-4-driven aggresome-like induced structure formation and autophagic degradation. Proc Natl Acad Sci USA 2011, 108:1427-1432.
27. Kriegenburg F., Poulsen E.G., Koch A., Kruger E., Hartmann-Petersen R. Redox control of the ubiquitin-proteasome system: from molecular mechanisms to functional significance. Antioxid Redox Signal 2011, 15:2265-2299.
28. Benham A., Neefjes J. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation. J Immunol 1997, 159:5896-5904.
29. Reits E.A., Hodge J.W., Herberts C.A., Groothuis T.A., Chakraborty M., Wansley E.K., Camphausen K., Luiten R.M., de Ru A.H., Neijssen J., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006, 203:1259-1271.
30. Netzer N., Goodenbour J.M., David A., Dittmar K.A., Jones R.B., Schneider J.R., Boone D., Eves E.M., Rosner M.R., Gibbs J.S., et al. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature 2009, 462:522-526.
31. Tanaka M., Chock P.B., Stadtman E.R. Oxidized messenger RNA induces translation errors. Proc Natl Acad Sci USA 2007, 104:66-71.
32. Schubert U., Antón L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
33. Reits E.A., Vos J.C., Grommé M., Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000, 404:774-778.
34. Schmidt N., Gonzalez E., Visekruna A., Kuhl A.A., Loddenkemper C., Mollenkopf H., Kaufmann S.H., Steinhoff U., Joeris T. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 2010, 59:896-906.
35. Hayashi T., Kodama S., Faustman D.L. Reply to 'LMP2 expression and proteasome activity in NOD mice'. Nat Med 2000, 6:1065-1066.
36. Opitz E., Koch A., Klingel K., Schmidt F., Prokop S., Rahnefeld A., Sauter M., Heppner F., Völker U., Kandolf R., et al. Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog 2011, 7:e1002233.
37. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
38. Agarwal A.K., Xing C., DeMartino G.N., Mizrachi D., Hernandez M.D., Sousa A.B., Martinez de Villarreal L., dos Santos H.G., Garg A. PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 2010, 87:866-872.
39. Kitamura A., Maekawa Y., Uehara H., Izumi K., Kawachi I., Nishizawa M., Toyoshima Y., Takahashi H., Standley D.M., Tanaka K., et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 2011, 121:4150-4160.
40. Arima K., Kinoshita A., Mishima H., Kanazawa N., Kaneko T., Mizushima T., Ichinose K., Nakamura H., Tsujino A., Kawakami A., et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci USA 2011, 108:14914-14919.
41. Zaiss D.M., Bekker C.P., Grone A., Lie B.A., Sijts A.J. Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. J Immunol 2011, 187:2302-2309.
42. Sijts A.J., Ruppert T., Rehermann B., Schmidt M., Koszinowski U., Kloetzel P.M. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med 2000, 191:503-514.
43. Callahan M.K., Wohlfert E.A., Menoret A., Srivastava P.K. Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes. J Immunol 2006, 177:8393-8399.
44. Khan M.A., Oubrahim H., Stadtman E.R. Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome. Proc Natl Acad Sci USA 2004, 101:11560-11565.
45. Zheng P.Z., Wang K.K., Zhang Q.Y., Huang Q.H., Du Y.Z., Zhang Q.H., Xiao D.K., Shen S.H., Imbeaud S., Eveno E., et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci USA 2005, 102:7653-7658.
46. Kotamraju S., Matalon S., Matsunaga T., Shang T., Hickman-Davis J.M., Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med 2006, 40:1034-1044.
47. Puttaparthi K., Elliott J.L. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol 2005, 196:441-451.
48. Diaz-Hernandez M., Hernandez F., Martin-Aparicio E., Gomez-Ramos P., Moran M.A., Castano J.G., Ferrer I., Avila J., Lucas J.J. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci 2003, 23:11653-11661.
49. Ferrer I., Boada Rovira M., Sanchez Guerra M.L., Rey M.J., Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 2004, 14:11-20.
50. Caudill C.M., Jayarapu K., Elenich L., Monaco J.J., Colbert R.A., Griffin T.A. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J Immunol 2006, 176:4075-4082.
51. Muchamuel T., Basler M., Aujay M.A., Suzuki E., Kalim K.W., Lauer C., Sylvain C., Ring E.R., Shields J., Jiang J., et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med 2009, 15:781-787.
52. Moebius J., van den Broek M., Groettrup M., Basler M. Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. Eur J Immunol 2010, 40:3439-3449.
53. Basler M., Dajee M., Moll C., Groettrup M., Kirk C.J. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. J Immunol 2010, 185:634-641.